MX2012004082A - Inhibidores de cxcr1/2 como adyuvantes en el trasplante de islotes pancreaticos. - Google Patents

Inhibidores de cxcr1/2 como adyuvantes en el trasplante de islotes pancreaticos.

Info

Publication number
MX2012004082A
MX2012004082A MX2012004082A MX2012004082A MX2012004082A MX 2012004082 A MX2012004082 A MX 2012004082A MX 2012004082 A MX2012004082 A MX 2012004082A MX 2012004082 A MX2012004082 A MX 2012004082A MX 2012004082 A MX2012004082 A MX 2012004082A
Authority
MX
Mexico
Prior art keywords
cxcr1
transplant
inhibitors
pancreatic islets
adjuvants
Prior art date
Application number
MX2012004082A
Other languages
English (en)
Spanish (es)
Inventor
Lorenzo Piemonti
Luisa Daffonchio
Marcello Allegretti
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Publication of MX2012004082A publication Critical patent/MX2012004082A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51Y being a hydrogen or a carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2012004082A 2009-10-06 2010-10-06 Inhibidores de cxcr1/2 como adyuvantes en el trasplante de islotes pancreaticos. MX2012004082A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172364A EP2308484A1 (en) 2009-10-06 2009-10-06 Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
PCT/EP2010/064921 WO2011042466A1 (en) 2009-10-06 2010-10-06 Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets

Publications (1)

Publication Number Publication Date
MX2012004082A true MX2012004082A (es) 2012-07-25

Family

ID=41818891

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004082A MX2012004082A (es) 2009-10-06 2010-10-06 Inhibidores de cxcr1/2 como adyuvantes en el trasplante de islotes pancreaticos.

Country Status (24)

Country Link
US (1) US20120202884A1 (https=)
EP (2) EP2308484A1 (https=)
JP (2) JP5834010B2 (https=)
KR (2) KR101759362B1 (https=)
CN (2) CN104906572A (https=)
AU (1) AU2010305385B2 (https=)
BR (1) BR112012007991B8 (https=)
CA (1) CA2775902C (https=)
CY (1) CY1115018T1 (https=)
DK (1) DK2485723T3 (https=)
EA (1) EA021298B1 (https=)
ES (1) ES2451349T3 (https=)
HK (1) HK1213777A1 (https=)
HR (1) HRP20140202T1 (https=)
IL (1) IL219037A (https=)
ME (1) ME01719B (https=)
MX (1) MX2012004082A (https=)
NZ (1) NZ599172A (https=)
PL (1) PL2485723T3 (https=)
PT (1) PT2485723E (https=)
RS (1) RS53249B (https=)
SI (1) SI2485723T1 (https=)
SM (1) SMT201400033B (https=)
WO (1) WO2011042466A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2308484A1 (en) * 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
EP2308485A1 (en) * 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
CN103159652B (zh) * 2011-12-19 2016-06-08 天津市国际生物医药联合研究院 亚磺酰胺类化合物的制备及其应用
WO2014205127A2 (en) 2013-06-18 2014-12-24 New York University Cellular factors involved in the cytotoxicity of staphylococcus aureus leukocidins: novel therapeutic targets
US11291641B2 (en) * 2016-10-03 2022-04-05 The Children's Medical Center Corporation Prevention and treatment of diabetic nephropathy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303249B1 (it) 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
AU2001253496A1 (en) * 2000-04-14 2001-10-30 Millennium Pharmaceuticals, Inc. Treating graft rejection with cxcr3 inhibitors
US20020042370A1 (en) * 2000-04-14 2002-04-11 Millennium Pharmaceuticals, Inc. Method of treating graft rejection using inhibitors of CCR2 function
ITMI20010206A1 (it) * 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
ATE444286T1 (de) 2004-03-23 2009-10-15 Dompe Pha R Ma Spa Res & Mfg 2-phenylpropionsäurederivate und diese enthaltende pharmazeutische zusammensetzung
PT1579859E (pt) 2004-03-25 2007-03-30 Dompe Pha R Ma Spa Res & Mfg Utilização de n-(2-aril-propionil)-sulfonamidas pata o tratamento de lesões da medula espinal
US20050261762A1 (en) * 2004-05-21 2005-11-24 Medtronic Vascular, Inc. Medical devices to prevent or inhibit restenosis
EP1790637B1 (en) * 2004-09-13 2014-01-29 Ono Pharmaceutical Co., Ltd. Derivatives of N-4-piperidyl urea and medicaments containing them as active ingredient
JP5232144B2 (ja) * 2006-06-28 2013-07-10 サノフイ Cxcr2阻害剤
WO2008039876A1 (en) * 2006-09-26 2008-04-03 Case Western Reserve University Cytokine signaling
CN102088993A (zh) 2008-03-20 2011-06-08 卡罗勒斯治疗公司 炎症的治疗方法
EP2308484A1 (en) * 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets

Also Published As

Publication number Publication date
CN104906572A (zh) 2015-09-16
JP2015145404A (ja) 2015-08-13
EA021298B1 (ru) 2015-05-29
IL219037A0 (en) 2012-06-28
KR101759362B1 (ko) 2017-07-18
PL2485723T3 (pl) 2014-07-31
BR112012007991A2 (pt) 2017-07-25
JP6097328B2 (ja) 2017-03-15
US20120202884A1 (en) 2012-08-09
CA2775902A1 (en) 2011-04-14
KR101817912B1 (ko) 2018-02-21
BR112012007991B1 (pt) 2020-12-15
CN102665703B (zh) 2016-04-20
ME01719B (me) 2014-09-20
SMT201400033B (it) 2014-07-07
EP2308484A1 (en) 2011-04-13
AU2010305385B2 (en) 2016-04-21
CN102665703A (zh) 2012-09-12
SI2485723T1 (sl) 2014-06-30
HK1175993A1 (zh) 2013-07-19
EP2485723B1 (en) 2013-12-11
JP2013506704A (ja) 2013-02-28
WO2011042466A1 (en) 2011-04-14
HRP20140202T1 (en) 2014-05-23
BR112012007991B8 (pt) 2021-05-25
JP5834010B2 (ja) 2015-12-16
CY1115018T1 (el) 2017-01-25
IL219037A (en) 2015-01-29
KR20170068625A (ko) 2017-06-19
PT2485723E (pt) 2014-03-13
CA2775902C (en) 2016-11-29
ES2451349T3 (es) 2014-03-26
NZ599172A (en) 2014-03-28
KR20120083440A (ko) 2012-07-25
RS53249B (sr) 2014-08-29
HK1213777A1 (zh) 2016-07-15
AU2010305385A1 (en) 2012-04-26
EP2485723A1 (en) 2012-08-15
EA201270513A1 (ru) 2012-11-30
DK2485723T3 (en) 2014-03-17

Similar Documents

Publication Publication Date Title
MY149648A (en) Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
MX2010002419A (es) (ciclopropilfenil) feniloxamidas, metodo para su produccion y uso como un medicamento.
MX2010007952A (es) Arilpirrolinas insecticidas.
IN2012DN01233A (https=)
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
BR112012016797A2 (pt) intensificador dinâmico de baixo utilizando compressor com equalizador incorporado
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
PH12013500329A1 (en) New compounds
MX2011011733A (es) Inhiibidores de dihidroorotato deshidrogenasa como compuestos virostaticos.
PH12013501175A1 (en) 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
EA201270216A1 (ru) Фармацевтический состав
UA104885C2 (uk) Ізотіазолілоксифеніламідини та їх застосування як фунгіцидів
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
MX2013006802A (es) Inhibidores de neprilisina.
MX2011012739A (es) Derivados fluorados de aminotriazol.
IN2012DN01292A (https=)
EA201171339A1 (ru) Способ снижения внутриглазного давления у людей
PH12013500644A1 (en) Co-crystals and salts of ccr3-inhibitors
WO2011047055A8 (en) Novel mek inhibitors, useful in the treatment of diseases
WO2009105969A8 (zh) 埃坡霉素类似物、其药物组合物、用途及其制备方法
MX2012004082A (es) Inhibidores de cxcr1/2 como adyuvantes en el trasplante de islotes pancreaticos.
UA103329C2 (ru) Соли соединений-ингибиторов вич
MY152040A (en) Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
MY148732A (en) Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
MX2012007426A (es) Derivados de amino-heteroarilo como bloqueadores de los canales activados por la hiperpolarizacion, controlados por nucleotidos ciclicos.

Legal Events

Date Code Title Description
FG Grant or registration